ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

LncRNA RP11-58O9.2 predicts poor prognosis and promotes progression of non-small cell lung cancer

Miao, Xuan; Xi, Wen; Bao, Yongxia*哈尔滨医科大学
Journal of International Medical Research2023-10DOI: 10.1177/03000605231206295
4阅读
引用收藏
分享

摘要

ObjectiveLong non-coding RNAs (lncRNAs) play a crucial role in non-small cell lung cancer (NSCLC). This study aimed to investigate the novel biomarker, lncRNA RP11-58O9.2, in patients with NSCLC.MethodsRP11-58O9.2 expression in NSCLC cells and tissues was detected by reverse transcription-quantitative polymerase chain reaction. Patient survival was analyzed in relation to RP11-58O9.2 expression levels. RP11-58O9.2 expression was knocked down and endogenous expression was verified in two NSCLC cell lines. Cell proliferation was then assessed by Cell Counting Kit-8 and colony-formation assays, and cell invasion and migration were assessed by Transwell and wound-healing assays, respectively. In vivo experiments were performed in mice, and the combination of RP11-58O9.2 and miR-6749-3p was predicted by miRanda.ResultsRP11-58O9.2 was highly expressed in NSCLC cell lines and tissues, and was associated with advanced stage, lymphatic metastasis, and differentiation group. High RP11-58O9.2 levels were also associated with shorter survival. RP11-58O9.2 knockdown inhibited the proliferation, invasion, and migration of lung cancer cells, and tumor growth in mouse xenografts in vivo. RP11-58O9.2 may target and regulate miR-6749-3p.ConclusionsLncRNA RP11-58O9.2 is associated with NSCLC prognosis and promotes lung cancer progression. Further studies are needed to investigate the mechanisms and the regulatory association between RP11-58O9.2 and miR-6749-3p.

学科与关键词

关键词
Biological targeted therapylymphatic metastasislong non-coding RNAnon-small cell lung cancersurvival
相关
加载中…
  • Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer
    Min, Ling; Zhu, Ting; Lv, Bo; An, Taixue; Zhang, Qichao; Shang, Yanyan; Yu, Zhiwu; Zheng, Lei; Wang, Qian*International Journal of Clinical Oncology, 2022, 27(6): 1013-1024.被引 15
  • Construction of a 5 immune-related lncRNA-based prognostic model of NSCLC via bioinformatics
    Huang, Ya-jie*; Huang, Chang-jieMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2021, 100(37): e27222.被引 3
  • Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment
    Xian, Jianfeng; Zeng, Yuyuan; Chen, Shizhen; Lu, Liming; Liu, Li; Chen, Jinbin; Rao, Boqi; Zhao, Zhuxiang; Liu, Jun; Xie, Chenli; Zhu, Lingling; Zhang, Duo; Qiu, Fuman; Lu, Jiachun; Yang, Lei*Carcinogenesis, 2021, 42(6): 831-841.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of International Medical Research
发表日期
2023-10
卷期
第 51 卷, 第 10 期
页码
03000605231206295
DOI
10.1177/03000605231206295
语言
ENGLISH
成果收录
SCIE
资助标注
We would like to express our gratitude to the laboratory supervisor for their attentive guidance. We would also like to thank the students who provided us with assistance, including Guanyu Li, Han Wang, and Feng Zhou. We also greatly appreciate the assista

作者

  • M

    Miao, Xuan (第一作者)

    2 · harbin med univ

  • X

    Xi, Wen

    2 · harbin med univ

查看全部 3 位作者收起作者
  • B

    Bao, Yongxia (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417